CM
ESPR

Caption Management’s Esperion Therapeutics ESPR Stock Holding History

Caption Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,074,000
Closed -$5.68M – 1784
2026
Q1 		$5.68M Sell
2,074,000
-68,500
-3% -$217K 0.03% 498
2025
Q4 		$7.93M Buy
+2,142,500
New +$6.92M 0.05% 391
2025
Q1 		– Sell
-323,800
Closed -$712K – 1668
2024
Q4 		$712K Sell
323,800
-45,000
-12% -$105K 0.01% 995
2024
Q3 		$609K Hold
368,800
– – 0.01% 895
2024
Q2 		$819K Buy
368,800
+143,800
+64% +$338K 0.01% 711
2024
Q1 		$603K Hold
225,000
– – 0.01% 838
2023
Q4 		$673K Sell
225,000
-148,800
-40% -$193K 0.01% 891
2023
Q3 		$366K Hold
373,800
– – 0.01% 999
2023
Q2 		$520K Sell
373,800
-473,300
-56% -$661K 0.01% 812
2023
Q1 		$1.35M Sell
847,100
-916,400
-52% -$4.73M 0.03% 556
2022
Q4 		$11M Buy
1,763,500
+819,600
+87% +$5.86M 0.17% 148
2022
Q3 		$6.32M Buy
+943,900
New +$6.48M 0.09% 272
2022
Q2 		– Sell
-200,000
Closed -$928K – 1549
2022
Q1 		$928K Buy
+200,000
New +$858K 0.01% 1003
2021
Q3 		– Sell
-75,000
Closed -$1.59M – 1590
2021
Q2 		$1.59M Buy
+75,000
New +$1.81M 0.02% 764
2020
Q4 		– Sell
-15,000
Closed -$558K – 1059
2020
Q3 		$558K Hold
15,000
– – 0.01% 747
2020
Q2 		$770K Sell
15,000
-12,000
-44% -$502K 0.03% 588
2020
Q1 		$852K Sell
27,000
-53,000
-66% -$2.8M 0.05% 437
2019
Q4 		$4.77M Buy
80,000
+50,000
+167% +$2.25M 0.16% 172
2019
Q3 		$1.1M Sell
30,000
-75,000
-71% -$2.97M 0.06% 361
2019
Q2 		$4.88M Buy
+105,000
New +$4.93M 0.25% 118
2019
Q1 		– Sell
-30,000
Closed -$1.38M – 614
2018
Q4 		$1.38M Buy
+30,000
New +$1.45M 0.11% 224

Other funds holding ESPR

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Caption Management's ESPR Position: Q1 2024 in Review

Caption Management sold out of Esperion Therapeutics (ESPR) in Q1 2024, closing a stake of 31,600 shares — an estimated $76.8K sold.

Caption Management first reported a position in ESPR in Q4 2018 and held it in 9 quarters. The position peaked at $1.1M in Q2 2020. 153 funds tracked by Wall St. Rank hold ESPR as of Q1 2024.

  • Caption Management reported no remaining Esperion Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Caption Management sold 31,600 Esperion Therapeutics shares in Q1 2024, an estimated $76.8K.
  • Caption Management first reported a position in Esperion Therapeutics in Q4 2018 and held it in 9 quarters.
  • Caption Management's Esperion Therapeutics position peaked at $1.1M in Q2 2020.
  • 153 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2024.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.